Effect of human albumin on TCD vasospasm, DCI, And cerebral infarction in subarachnoid hemorrhage: The Alisah study

Acta Neurochirurgica, Supplementum

Volumn 120, Issue , 2015, Pages 287-290

  Suarez, Jose I ^a   Martin, R H ^b   Calvillo, E ^a   Bershad, E M ^a   Venkatasubba Rao, C P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Clinical trials; Delayed cerebral ischemia; Human albumin; Subarachnoid hemorrhage; Transcranial Doppler ultrasound

Indexed keywords

HUMAN ALBUMIN; ALBUMINOID; NEUROPROTECTIVE AGENT;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DELAYED CEREBRAL ISCHEMIA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MEAN CEREBRAL BLOOD FLOW VELOCITY; NEUROPROTECTION; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER; CLINICAL TRIAL; COMPLICATION; DOPPLER ECHOGRAPHY; DOSE RESPONSE; MULTICENTER STUDY; PILOT STUDY; STROKE; VASOSPASM, INTRACRANIAL;

ALBUMINS; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUROPROTECTIVE AGENTS; PILOT PROJECTS; STROKE; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VASOSPASM, INTRACRANIAL;

EID: 84921726688     PISSN: 00651419     EISSN: 21978395     Source Type: Book Series    
DOI: 10.1007/978-3-319-04981-6_48     Document Type: Article

References (10)

1. Belayev L, Liu Y, Zhao W, Busto R, Ginsberg MD (2001) Human albumin therapy of acute ischemic stroke: marked neuroprotective effi cacy at moderate doses and with a broad therapeutic window. Stroke 32:553–560
2. Belayev L, Zhao W, Pattany PM, Weaver RG, Huh PW, Lin B (1998) Diffusion-weighted magnetic resonance imaging confi rms marked neuroprotection effi cacy of albumin therapy in focal cerebral ischemia. Stroke 29:2587–2599
3. Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P et al (2011) Critical Care Management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care 15:211–240
4. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J et al (2012) Magnesium for aneurysmal subarachnoid hemorrhage (MASH-2): a randomized placebo-controlled trial. Lancet 380:44–49
5. Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ et al (2011) The Albumin in Acute Stroke Part 1 trial: an exploratory efficacy analysis. Stroke 42:1621–1625
6. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al (2012) Randomized trials of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 43:1463–1469
7. Suarez JI, Martin RH, Calvillo E, Dillon C, Bershad EM, Macdonald RL et al (2012) The Albumin In Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes. Stroke 43:683–690
8. Suarez JI, Martin RH (2010) Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design. Neurocrit Care 13:262–277
9. Suarez JI, Qureshi AI, Yahia AB, Parekh PD, Tamargo RJ, Williams MA et al (2002) Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution. Crit Care Med 30:1348–1355
10. Suarez JI, Tarr RW, Selman WR (2006) Aneurysmal subarachnoid hemorrhage. N Engl J Med 354:387–396